FGF21 and obesity due to melanocortin 4 receptor deficiency: However, elevated levels of FGF-21 are reported in individuals with type 2 diabetes, obesity, and cardiovascular disease, and FGF-21 is therefore suggested as a biomarker of these conditions [32, 33].